Immunitybio Stock Forward View - Unknown Technical Ratio
| IBRX Stock | USD 7.42 -1.98 -21.06% |
The Current Valuation reference data for Immunitybio is derived from the equity's published trading history. The resulting forecast and deviation statistics are presented as reference data for informational context. Forecast values and accuracy statistics are presented for informational purposes. All values shown are derived from publicly available market data.
The forecast reference data presented here for Immunitybio reflects Current Valuation model output and is intended as reference material for analytical use. Current Valuation Analysis Today
Immunitybio has current Current Valuation of 0.| Volatility | Backtest | Information Ratio |
Immunitybio Trading Date Momentum
| On March 24 2026 Immunitybio was traded for 7.42 at the closing time. The top price for the day was 9.15 and the lowest listed price was 6.54 . The trading volume for the day was 86.6 M. The trading history from March 24, 2026 did not cause price change. The trading delta at closing time against the current closing price is 22.51% . |
| Compare Immunitybio to competition |
Other Forecasting Options for Immunitybio
Fibonacci retracement levels applied to Immunitybio Stock price swings identify potential support and resistance zones. Extreme price moves in Immunitybio occur more frequently than standard risk models assume. Support and resistance levels derived from Immunitybio's historical data identify zones where buying or selling pressure has stalled moves. A volume spike without a corresponding price move can signal accumulation or distribution ahead of a directional breakout.Immunitybio Related Equities
The peer firms below within the Health Care space can help frame Immunitybio's pricing and running costs in context. Looking at Immunitybio's pricing multiples next to these peers shows if the stock trades at a premium or discount. Peer pricing works best when the firms compared share similar business models and end markets.
| Risk & Return | Correlation |
Immunitybio Market Strength Events
Tracking market strength indicators for Immunitybio provides context for understanding stock momentum dynamics. Tracking these indicators helps identify periods where trading Immunitybio is likely to be most rewarding. These tools are essential for timing trades in Immunitybio with a quantitative framework. Market strength indicators for Immunitybio are most useful when viewed as part of a broader analytical framework.
Immunitybio Risk Indicators
Properly assessing Immunitybio's risk indicators is a prerequisite for building reliable price forecasts. This analysis provides context for determining the appropriate level of risk to accept when holding Immunitybio's. Analyzing Immunitybio's risk indicators provides a critical input for investment risk management. By quantifying the risk in Immunitybio's investment, investors can make more informed decisions about hedging strategies.
| Mean Deviation | 7.07 | |||
| Semi Deviation | 6.21 | |||
| Standard Deviation | 10.81 | |||
| Variance | 116.82 | |||
| Downside Variance | 62.93 | |||
| Semi Variance | 38.59 | |||
| Expected Short fall | -8.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Immunitybio
Story coverage around Immunitybio often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Immunitybio Short Properties
Reviewing short-oriented indicators for Immunitybio is useful because long and short participants often create very different signals for timing and volatility. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
| Common Stock Shares Outstanding | 919.9 M | |
| Cash And Short Term Investments | 242.8 M |